Pictured the Massachusetts State House in Boston.


September 22, 2014

Nanobiotix (EPA:NANO), the French technologyfirm pioneering a breakthrough in the field of radiotherapy, said it is setting up shop in Boston as well making a senior appointment to lead the new operation.

The area around the American city is one of the world’s centres for life sciences, as well as being home to world leading universities such as Harvard and MIT.

Nanobiotix chief executive Laurent Lévy said: “The Boston area is the ideal location for us to access new talent, innovative research and clinical expertise in the nanomedicine.”

The company has appointed Patrick Tricoli, a 25-year veteran of the pharma industry, to lead the US push.

In recent years Tricoli has focused on internationalbusiness development and partnering activities and is a doctor of pharmaceutical sciences with a master degree in pharmacology and pharmacokinetics.

He said: “Among hundreds of innovative projects I reviewed in my previous roles with both R&D and business development perspectives, I am firmly convinced that Nanobiotix’ disruptive approach could be the future of the healthcare industry. I am pleased to join this team with whom I share the same values, ambitions and passion.”


No comments

Be the first one to leave a comment.

Post a Comment